CommercialBilling CodesMedium impact
11.07.01ad, Hematopoietic Stem Cell Transplantation
Independence Blue Cross·Hematology, Oncology, Transplant Surgery +2 more·Medical Policy
Effective date
Oct 1, 2026
We identified it
Oct 2, 2026
Summary
Independence Blue Cross updated policy 11.07.01ad to add HCPCS code J3406 (omidubicel-onlv injection) for hematopoietic stem cell transplantation effective 10/01/2026, while removing two unclassified biologics codes (C9399 and J3590). Billing teams must update systems to recognize the new code for stem cell transplant procedures and stop using the removed codes to avoid claim rejections.
Action Required
By September 15, 2026: Billing team must update billing software and coding systems to recognize new HCPCS code J3406 (omidubicel-onlv) for hematopoietic stem cell transplant procedures under policy 11.07.01ad. Simultaneously remove codes C9399 and J3590 from active billing workflows to prevent claim denials. Update internal code mapping documentation and train billing staff on the new code application. Effective October 1, 2026, all claims for omidubicel-onlv stem cell transplants must use J3406 or claims will be denied. Verify that your billing system integrates with Independence Blue Cross commercial claims processing to ensure smooth submission.